Novo Nordisk A/S (TSX:NOVO)
17.01
+0.05 (0.29%)
Oct 26, 2026, 3:59 PM EDT
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of CAD 241.6 billion as of October 26, 2026. Its market cap has decreased by 27.19% in one year.
Market Cap
241.60B
Enterprise Value
261.56B
Revenue
71.49B
Global Rank
n/a
Country Rank
n/a
PE Ratio
9.94
ChartMarket Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 9.70B to 241.60B, an increase of 2,390.39%. That is a compound annual growth rate of 11.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 241.60B | -22.44% |
| Dec 30, 2025 | 311.50B | -43.89% |
| Dec 30, 2024 | 555.20B | -8.91% |
| Dec 29, 2023 | 609.54B | 47.94% |
| Dec 30, 2022 | 412.02B | 26.32% |
| Dec 30, 2021 | 326.16B | 56.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.34B |
| Curaleaf Holdings | 2.92B |
| Extendicare | 2.64B |
| Sienna Senior Living | 2.28B |
| Green Thumb Industries | 1.93B |
| Cronos Group | 1.73B |
| Knight Therapeutics | 1.14B |
| WELL Health Technologies | 1.08B |